Moreover, theophylline, a drug commonly used for asthma, has been shown to inhibit TGF-β-induced IL-6 expression in AECs, thereby suppressing Th17 differentiation and offering a potential therapeutic strategy for PF (Park et al., 2023). This evidence concerns the gene TGFB1 and pemphigus foliaceus.